VAERS reports by lot

Merck HPV lot R024264: VAERS reports

28 VAERS reports list lot R024264 as a Merck HPV vaccine, received between 2018-12-10 and 2019-12-05. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
28
Reports
0%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2145%
General / Systemic (non-local)1021%
Neurological511%
Dermatological (non-injection-site)36%
Gastrointestinal24%
Musculoskeletal24%
Cardiac / Cardiovascular12%
Allergic / Anaphylactic12%
Respiratory12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Michigan6
Pennsylvania3
Texas3
Florida3
Maryland2
Ohio2
Indiana2
Illinois1
New York1
California1
Georgia1
Arkansas1

Reports by month received

MonthReportsBar
2018-122
2019-014
2019-024
2019-035
2019-043
2019-051
2019-071
2019-115
2019-123

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Merck HPV lots (A–Z): R009614 · R017624 · R021636 · R027577 · S010729 · S022599

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.